The latest update on the PD solution shortage

By now, you have no doubt heard that Baxter has not been able to meet the demand for PD solution in the US, and has asked clinics to start only 25% of their usual number of new clients on PD as a result—through the end of 2014. Now, they have signed an agreement with Fresenius to help, and ISPD has weighed in on the challenge.

Read the full article » | Posted 09/05/2014

Related Articles